Inventor · disambiguated record
Gerald R. Nakamura
Also filed as: NAKAMURA GERALD · NAKAMURA GERALD R
17 granted patents·14 pending applications·428 citations·filing 1994–2024
94Inventor score
Top patents by PatentIndex Score
31 records- 0198US7799900B2Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2005·Granted Sep 21, 2010·103 cites·19 claims
- 0297US8562992B2Immunoglobulin variants and uses thereofADAMS CAMELLIA W·Filed 2008·Granted Oct 22, 2013·69 cites·6 claims
- 0397US6806055B2HIV envelopolype peptidesGENENTECH INC·Filed 2001·Granted Oct 19, 2004·86 cites·45 claims
- 0495US6331404B1HIV envelope polypeptidesGENENTECH INC·Filed 2000·Granted Dec 18, 2001·44 cites·20 claims
- 0594US6042836AHIV envelope polypeptidesGENENTECH INC·Filed 1998·Granted Mar 28, 2000·84 cites·15 claims
- 0692US10723795B2Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2018·Granted Jul 28, 2020·6 cites·67 claims
- 0786US10093730B2Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2015·Granted Oct 9, 2018·6 cites·58 claims
- 0883US11725050B2Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2020·Granted Aug 15, 2023·1 cites·28 claims
- 0976US9284365B2Anti-hemagglutinin antibodies and methods of useGENENTECH INC·Filed 2013·Granted Mar 15, 2016·2 cites·12 claims
- 1076US2022002430A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 1174US7101851B2IgE receptor antagonistsGENENTECH INC·Filed 2001·Granted Sep 5, 2006·7 cites·24 claims
- 1272US5864027AHIV envelope polypeptidesGENENTECH INC·Filed 1994·Granted Jan 26, 1999·19 cites·7 claims
- 1368US9745365B2Anti-influenza B virus hemagglutinin antibodies and methods of useGENENTECH INC·Filed 2015·Granted Aug 29, 2017·1 cites·15 claims
- 1466US2024092887A1Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 1565US2004121317A1HIV envelopolype peptidesGENENTECH INC·Filed 2003·Application pending·0 cites
- 1665US2019071511A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 1763US9067979B2Anti-hemagglutinin antibodies and methods of useGENENTECH INC·Filed 2014·Granted Jun 30, 2015·0 cites·13 claims
- 1863US2014154242A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2013·Application pending·0 cites
- 1961US11760797B2Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2021·Granted Sep 19, 2023·0 cites·27 claims
- 2061US2017158773A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 2159US2025002575A1Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 2259US2006024300A1Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2005·Application pending·0 cites
- 2358US2019023770A1Anti-hemagglutinin antibodies and methods of useGENENTECH INC·Filed 2018·Application pending·0 cites
- 2456US9908931B2Anti-hemagglutinin antibodies and methods of useGENENTECH INC·Filed 2016·Granted Mar 6, 2018·0 cites·19 claims
- 2555US9598481B2Anti-hemagglutinin antibodies and methods of useGENENTECH INC·Filed 2015·Granted Mar 21, 2017·0 cites·17 claims
- 2646US2017320937A1Anti-influenza b virus hemagglutinin antibodies and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 2745US2008181888A1Polypeptides That Bind Br3 and Uses ThereofAMBROSE CHRISTINE M·Filed 2005·Application pending·0 cites
- 2844US2006246004A1Antibody variants and uses thereofGENENTECH INC·Filed 2006·Application pending·0 cites
- 2943US2010280227A1Polypeptides that bind br3 and uses thereofGENENTECH INC·Filed 2010·Application pending·0 cites
- 3035US2016207995A1Anti-il-4 antibodies and bispecific antibodies and uses thereofGENENTECH INC·Filed 2015·Application pending·0 cites
- 3132US9315583B2Assays for detecting antibodies specific to therapeutic anti-IgE antibodies and their use in anaphylaxisFISCHER SALOUMEH·Filed 2010·Granted Apr 19, 2016·0 cites·40 claims
Join the waitlist — get patent alerts
Get an alert when Gerald R. Nakamura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →